93 related articles for article (PubMed ID: 16523924)
1. [Membranoproliferative glomerulonephritis: Pathogenesis, pathophysiology and therapy].
Ohi H
Nihon Rinsho; 2006 Feb; 64 Suppl 2():413-6. PubMed ID: 16523924
[No Abstract] [Full Text] [Related]
2. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of complement system abnormality and glomerulonephritis].
Ohi H; Kojima H; Seki M
Nihon Rinsho; 1988 Sep; 46(9):2030-4. PubMed ID: 3241392
[No Abstract] [Full Text] [Related]
4. [Membranoproliferative glomerulonephritis].
Kondo S; Kagami S
Nihon Rinsho; 2005 May; 63 Suppl 5():526-9. PubMed ID: 15954404
[No Abstract] [Full Text] [Related]
5. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
6. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
Power DA; Ng YC; Simpson JG
Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
[TBL] [Abstract][Full Text] [Related]
7. A case of renal sarcoidosis with complement activation via the lectin pathway.
Hagiwara S; Ohi H; Eishi Y; Kodama F; Tashiro K; Makita Y; Suzuki Y; Maeda K; Fukui M; Horikoshi S; Tomino Y
Am J Kidney Dis; 2005 Mar; 45(3):580-7. PubMed ID: 15754281
[TBL] [Abstract][Full Text] [Related]
8. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
West CD; Ruley EJ; Spitzer RE; Davis NC
Perspect Nephrol Hypertens; 1973; 1 Pt 1():531-40. PubMed ID: 4620926
[No Abstract] [Full Text] [Related]
9. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
[TBL] [Abstract][Full Text] [Related]
10. Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.
Lionaki S; Gakiopoulou H; Boletis JN
APMIS; 2016 Sep; 124(9):725-35. PubMed ID: 27356907
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
12. Does nephritic factor relate to the disease activity in hypocomplementemic membranoproliferative glomerulonephritis?
Ohi H; Tanuma Y
Nephron; 1992; 62(1):116. PubMed ID: 1436279
[No Abstract] [Full Text] [Related]
13. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
Whaley K; Ward D; Ruddy S
Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
[TBL] [Abstract][Full Text] [Related]
15. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
16. [Onset of glomerulonephritis after insect's bite].
Ianushkevich TN; Kukhtevich AV; Kireeva VI
Ter Arkh; 1998; 70(6):54-5. PubMed ID: 9695229
[No Abstract] [Full Text] [Related]
17. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.
Høgåsen K; Jansen JH; Mollnes TE; Hovdenes J; Harboe M
J Clin Invest; 1995 Mar; 95(3):1054-61. PubMed ID: 7883953
[TBL] [Abstract][Full Text] [Related]
18. Changes in nephritic factor in hypocomplementemia.
Ohi H; Tanuma Y; Sato M; Yasugi T
Nephron; 1993; 63(3):370. PubMed ID: 8446286
[No Abstract] [Full Text] [Related]
19. Anti-factor B autoantibody in dense deposit disease.
Strobel S; Zimmering M; Papp K; Prechl J; Józsi M
Mol Immunol; 2010 Apr; 47(7-8):1476-83. PubMed ID: 20193965
[TBL] [Abstract][Full Text] [Related]
20. [Activation of complement in membranoproliferative glomerulonephritis (author's transl)].
Oi H; Abe R; Kanazawa K
Nihon Jinzo Gakkai Shi; 1978 Jun; 20(6):658-62. PubMed ID: 739661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
